Taikang Asset Management (HK)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-500
Closed -$413K 106
2025
Q1
$413K Hold
500
0.06% 99
2024
Q4
$386K Hold
500
0.06% 99
2024
Q3
$443K Hold
500
0.05% 99
2024
Q2
$453K Buy
+500
New +$400K 0.07% 93

Other funds holding LLY

Taikang Asset Management (HK)'s LLY Position: Q2 2025 in Review

Taikang Asset Management (HK) sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 500 shares — an estimated $413K sold.

Taikang Asset Management (HK) first reported a position in LLY in Q2 2024 and held it in 4 quarters. The position peaked at $453K in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Taikang Asset Management (HK) reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Taikang Asset Management (HK) sold 500 Eli Lilly shares in Q2 2025, an estimated $413K.
  • Taikang Asset Management (HK) first reported a position in Eli Lilly in Q2 2024 and held it in 4 quarters.
  • Taikang Asset Management (HK)'s Eli Lilly position peaked at $453K in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Taikang Asset Management (HK)'s 13F filing for Q2 2025, filed 13 Aug 2025.